S. Yalcin Et Al. , "A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4, 2011
Yalcin, S. Et Al. 2011. A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4 .
Yalcin, S., Uslu, R., Dane, F., Yilmaz, U., Zengin, N., Buyukunal, E., ... Buyukberber, S.(2011). A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4.
Yalcin, S. Et Al. "A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4, 2011
Yalcin, S. Et Al. "A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4, 2011
Yalcin, S. Et Al. (2011) . "A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4.
@article{article, author={S. Yalcin Et Al. }, title={A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}